Description

ACP-105 can be taken orally and may be an effective SAR M

ACP-105, a novel non-steroidal SAR M. ACP-105 is shown to be as potent and efficacious as testosteron in in vitro assays without interaction at other hormone receptors. In addition, ACP-105 demonstrates potent anabolic effects on muscle and bone with minimal effect on prostrate in preclinical models.

ACP-105 is a non-steroidal and selective androgen receptor agonist. ACP-105 is part of a class of molecules referred to as selective androgen receptor modulator (SAR Ms). SAR Ms may advance the standard of treatment for a variety of disorders including muscle-wasting conditions and osteoporosis, with fewer side effects as compared to current treatments based on testosteron replacement. ACP-105 has exhibited promising pharmacological properties and a favorable safety profile in preclinical testing.